{"gene":"CLN8","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1999,"finding":"CLN8 encodes a novel putative transmembrane protein; a missense mutation (R24G) in EPMR patients and a frameshift insertion in mnd mice were identified as disease-causing, establishing CLN8 as the gene underlying these NCL phenotypes.","method":"Positional cloning, mutation analysis, sequence conservation analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — positional cloning with mutation identification replicated across human EPMR patients and mnd mouse model, independently confirming orthologous gene","pmids":["10508524"],"is_preprint":false},{"year":2000,"finding":"CLN8 protein (~33 kDa) is an ER-resident protein that cycles between the ER and ERGIC; the C-terminal KKRP motif acts as an ER-retrieval signal, as mutation of KKRP redirects CLN8 to the Golgi; the mnd mutant protein is restricted to the ER, while the EPMR mutation (R24G) does not alter ER-ERGIC localization.","method":"Confocal immunofluorescence microscopy with organelle markers, western blotting, pulse-chase analysis, site-directed mutagenesis of KKRP retrieval signal, expression in BHK/HeLa/CHO cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct localization with functional mutagenesis of ER retrieval signal, multiple cell lines, replicated with pulse-chase","pmids":["10861296"],"is_preprint":false},{"year":2002,"finding":"CLN8 was identified as a member of the TLC (TRAM-LAG1-CLN8) domain family, related to yeast Lag1p and mammalian TRAM, suggesting a conserved role in lipid sensing, ceramide synthesis, or lipid regulation in the ER.","method":"Bioinformatic sequence analysis and domain identification","journal":"Trends in biochemical sciences","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational/bioinformatic prediction only, no direct experimental validation of CLN8 function in this paper","pmids":["12151215"],"is_preprint":false},{"year":2004,"finding":"In mouse hippocampal neurons, CLN8 localizes to the ER (consistent with non-neuronal cells); in polarized epithelial CaCo-2 cells, CLN8 shows basolateral targeting; brain fractionation shows endogenous Cln8 in light membrane fractions distinct from ER in polarized cells. Disease-causing mutations do not alter intracellular localization in neuronal or non-neuronal cells.","method":"Semliki Forest virus-mediated expression, immunofluorescence microscopy with subcellular markers, subcellular fractionation of mouse brain tissue, polarized epithelial cell targeting assay","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct localization in primary neurons and polarized cells with fractionation, single lab, multiple complementary methods","pmids":["15160397"],"is_preprint":false},{"year":2009,"finding":"CLN8 plays a role in cell proliferation during neuronal differentiation and in protection against cell death; expression of native CLN8 or mutant forms (including novel p.Lys61del and three previously described missense mutations) in neuronal cell models, validated by gene silencing, demonstrated these functions.","method":"Overexpression of wild-type and mutant CLN8 in neuronal cell models, gene silencing (siRNA knockdown), cell proliferation and apoptosis assays","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — loss-of-function (silencing) and gain-of-function with defined cellular phenotype, single lab, two orthogonal approaches","pmids":["19431184"],"is_preprint":false},{"year":2010,"finding":"In CLN8(mnd) mice, ER stress markers are activated early and differentially across CNS regions: GRP78 upregulation and ATF6 activation occur presymptomatically in all regions; CHOP-dependent and caspase-12-dependent pathways are activated in a region-specific manner; NF-κB, TRAF2, TNF-α, and TNFR1 are also elevated, but ASK-1/JNK signaling is not activated. These ER stress responses contribute to CLN8(mnd) disease progression.","method":"Western blotting and immunohistochemistry for ER stress markers in Cln8mnd mouse CNS tissues at presymptomatic and symptomatic stages","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct measurement of ER stress pathway components in disease model, multiple regions and time points, single lab","pmids":["21094208"],"is_preprint":false},{"year":2011,"finding":"In Cln8(mnd) hippocampal neurons, mitochondrial Ca2+ uptake is specifically impaired, reducing Ca2+ clearance efficiency; SERCA-mediated ER Ca2+ uptake and plasma membrane Ca2+ extrusion are unaffected. Cln8mnd neurons show increased vulnerability to excitotoxic glutamate-induced Ca2+ deregulation.","method":"Patch clamp, fluorescence Ca2+ imaging, caged Ca2+ photolysis in hippocampal slices and cultured neurons from Cln8mnd mice; pharmacological dissection of Ca2+ clearance pathways","journal":"Cell calcium","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple electrophysiology and imaging methods in primary neurons, single lab, mechanistically specific (mitochondrial Ca2+ selective impairment)","pmids":["21917311"],"is_preprint":false},{"year":2012,"finding":"CLN8 protein interacts with VAPA, c14orf1/hERG28, STX8, GATE16, BNIP3 and BNIP3L by split-ubiquitin membrane yeast two-hybrid screen; interactions with VAPA and GATE16 were validated by co-immunoprecipitation and co-localization in mammalian cells and CNS tissues, implicating CLN8 in lipid transport, vesicular trafficking, autophagy/mitophagy, and apoptosis.","method":"Split-ubiquitin membrane yeast two-hybrid (MYTH) screen, co-immunoprecipitation, co-localization immunofluorescence in mammalian cells and CNS tissue","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — yeast two-hybrid with reciprocal Co-IP and co-localization validation for two partners, single lab","pmids":["23142642"],"is_preprint":false},{"year":2012,"finding":"CLN8-deficient cells show decreased ceramide synthase activity and reduced C16/C18:0/C24:0/C24:1 ceramide species (measured by MS), and CLN8 protein can complement defects in CLN5-deficient cells (growth, apoptosis), suggesting CLN8 and CLN5 are functionally related as activators of (dihydro)ceramide synthases.","method":"Ceramide synthase activity assay, mass spectrometry of ceramide species in CLN8-/- cells, complementation of CLN5-deficient cells by CLN8 overexpression","journal":"Electrophoresis","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct enzymatic activity measurement and MS quantification in disease cells, complementation assay, single lab","pmids":["23160995"],"is_preprint":false},{"year":2018,"finding":"CLN8 functions as an ER cargo receptor for lysosomal enzymes: it binds lysosomal enzymes via its second luminal loop (binding abolished by disease-causing mutations in this region), and traffics from ER to Golgi via COPII (export signal) and COPI (retrieval signal) interactions in its cytosolic C-terminus. CLN8 deficiency depletes soluble lysosomal enzymes and impairs lysosome biogenesis.","method":"Co-immunoprecipitation, domain mapping and mutagenesis (luminal loop, COPII/COPI signals), lysosomal enzyme activity assays, CLN8 knockdown/knockout with lysosomal functional readouts","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (Co-IP, mutagenesis of functional domains, trafficking assays, enzyme activity), mechanistically rigorous, published in high-impact journal","pmids":["30397314"],"is_preprint":false},{"year":2018,"finding":"CLN8 interacts with PP2A and its inhibitor I2PP2A; CLN8-deficient patient fibroblasts show decreased phosphorylation of PP2A substrates Akt, S6 kinase, and GSK3β (reversed by PP2A inhibitor cantharidin), indicating elevated PP2A activity. Ceramide levels are reduced by ~60% in CLN8-deficient cells, but ER-to-Golgi ceramide transport is not impaired.","method":"Co-immunoprecipitation of CLN8 with PP2A/I2PP2A, phosphorylation assays in patient fibroblasts, cantharidin rescue experiment, NBD-C6-ceramide transport assay, ceramide quantification","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP for protein interaction, pharmacological rescue, lipid transport assay, single lab","pmids":["30453012"],"is_preprint":false},{"year":2020,"finding":"CLN6 forms an obligate complex with CLN8 (termed EGRESS: ER-to-Golgi relaying of enzymes of the lysosomal system) to recruit and transport lysosomal enzymes from the ER to the Golgi; the second luminal loop of CLN6 is required for enzyme binding but not for CLN6-CLN8 interaction. Mice lacking both CLN6 and CLN8 do not show aggravated pathology compared to single knockouts, confirming the complex acts as a functional unit.","method":"Co-immunoprecipitation, domain mutagenesis (CLN6 luminal loop), lysosomal enzyme trafficking assays in vitro and in vivo, double-knockout mouse epistasis analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reciprocal Co-IP, domain mutagenesis, in vivo double-knockout epistasis, multiple orthogonal methods confirming complex and functional unit","pmids":["32597833"],"is_preprint":false},{"year":2021,"finding":"CLN8 knockdown in neuronal and non-neuronal cells increases Golgi apparatus size, increases the number and speed of mobile endo-lysosomes, and causes lysosomal alkalinization (detected with mApple-LAMP1-pHluorin). In primary rat hippocampal neurons, CLN8 knockdown reduces dendritic complexity and size, establishing a role for CLN8 in endo-lysosomal dynamics and somatodendritic development.","method":"shRNA knockdown, live fluorescence imaging (mApple-LAMP1-pHluorin pH reporter), vesicle tracking, Golgi morphometry, dendritic morphology analysis in primary neurons","journal":"Biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — loss-of-function with multiple functional readouts in neuronal and non-neuronal cells, single lab, direct functional imaging","pmids":["34021618"],"is_preprint":false},{"year":2024,"finding":"CLN8 deficiency impairs autophagy in a zebrafish model; autophagy modulators trehalose and SG2 attenuate the pathological phenotype in cln8-deficient zebrafish larvae, establishing autophagy impairment as a secondary pathological event in CLN8 disease.","method":"Zebrafish cln8 knockout model, autophagy pathway analysis, pharmacological rescue with trehalose and SG2","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — in vivo loss-of-function model with pharmacological rescue establishing pathway involvement, single lab","pmids":["38763444"],"is_preprint":false},{"year":2025,"finding":"CLN8 is a lysophosphatidylglycerol (LPG) acyltransferase that catalyzes an essential step in the biosynthesis of bis(monoacylglycero)phosphate (BMP), a phospholipid critical for lysosome function; this establishes CLN8 as a phospholipid remodeling enzyme within the TRAM-LAG1-CLN8 (TLC) domain protein family.","method":"In vitro acyltransferase activity assay, lipidomics, biochemical reconstitution of BMP biosynthesis, comparison with paralog TLCD1 (lysophosphatidylethanolamine acyltransferase)","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic reconstitution establishing acyltransferase activity, lipidomic validation, mechanistically definitive","pmids":["39970228"],"is_preprint":false}],"current_model":"CLN8 is an ER-resident transmembrane protein that functions as both a lysophosphatidylglycerol acyltransferase (catalyzing a key step in bis(monoacylglycero)phosphate biosynthesis critical for lysosome function) and an ER cargo receptor: in complex with CLN6 (the EGRESS complex), CLN8 binds lysosomal enzymes via its second luminal loop and shuttles them from the ER to the Golgi via COPII export and COPI retrieval signals in its cytosolic C-terminus, with CLN8 deficiency depleting lysosomal enzymes, impairing lysosome biogenesis, dysregulating ceramide levels, elevating PP2A activity, and causing endo-lysosomal dysfunction and neurodegeneration."},"narrative":{"mechanistic_narrative":"CLN8 is an ER-resident transmembrane protein of the TRAM-LAG1-CLN8 (TLC) domain family that links lysosomal enzyme delivery and phospholipid metabolism, and whose loss causes neuronal ceroid lipofuscinosis: distinct mutations underlie human EPMR (R24G) and the murine mnd phenotype [PMID:10508524]. The protein localizes to the ER and cycles to the ERGIC, with a C-terminal KKRP motif serving as an ER-retrieval signal whose mutation redirects CLN8 to the Golgi [PMID:10861296]. Mechanistically, CLN8 acts as an ER cargo receptor for soluble lysosomal enzymes, binding them through its second luminal loop—an interaction abolished by disease mutations in this region—and shuttling them from the ER to the Golgi via COPII export and COPI retrieval signals in its cytosolic C-terminus, such that CLN8 deficiency depletes lysosomal enzymes and impairs lysosome biogenesis [PMID:30397314]. This receptor function is executed within an obligate complex with CLN6 (the EGRESS complex), which operates as a single functional unit [PMID:32597833]. Independently, CLN8 is a lysophosphatidylglycerol acyltransferase catalyzing an essential step in biosynthesis of the lysosomal phospholipid bis(monoacylglycero)phosphate (BMP) [PMID:39970228]. CLN8 loss perturbs sphingolipid homeostasis, reducing ceramide synthase activity and ceramide species [PMID:23160995], and elevates PP2A activity through interaction with PP2A and its inhibitor I2PP2A [PMID:30453012]. Downstream consequences include endo-lysosomal dysfunction with Golgi enlargement and lysosomal alkalinization [PMID:34021618], impaired autophagy [PMID:38763444], and ER stress and calcium-handling defects in disease models [PMID:21094208, PMID:21917311].","teleology":[{"year":1999,"claim":"Established the genetic identity of CLN8, answering which gene underlies EPMR and the mnd neurodegenerative phenotype.","evidence":"Positional cloning and mutation analysis in human EPMR patients and mnd mice","pmids":["10508524"],"confidence":"High","gaps":["Protein function unknown at this stage","No subcellular localization or biochemical activity defined"]},{"year":2000,"claim":"Defined CLN8 as an ER-resident protein cycling to the ERGIC and identified the KKRP C-terminal ER-retrieval signal, framing it as a trafficking/secretory pathway component.","evidence":"Confocal immunofluorescence, pulse-chase, and site-directed mutagenesis of the KKRP motif in multiple cell lines","pmids":["10861296"],"confidence":"High","gaps":["Cargo or molecular activity not identified","Mechanism of retrieval beyond signal mapping unresolved"]},{"year":2002,"claim":"Placed CLN8 in the TLC domain family, raising the hypothesis of a lipid-related ER function.","evidence":"Bioinformatic sequence and domain analysis","pmids":["12151215"],"confidence":"Low","gaps":["Computational prediction only, no experimental validation of lipid function in this work","Specific enzymatic activity not demonstrated"]},{"year":2009,"claim":"Linked CLN8 to cellular phenotypes of neuronal proliferation and survival, moving beyond localization toward functional consequence.","evidence":"Overexpression of wild-type/mutant CLN8 and siRNA silencing in neuronal cell models with proliferation and apoptosis assays","pmids":["19431184"],"confidence":"Medium","gaps":["Molecular mechanism behind proliferation/survival role not defined","Single lab, cell-model based"]},{"year":2011,"claim":"Connected CLN8 loss to ER stress and impaired mitochondrial calcium handling, identifying stress pathways contributing to disease progression.","evidence":"ER stress marker profiling in Cln8mnd CNS and electrophysiology/Ca2+ imaging in mutant hippocampal neurons","pmids":["21094208","21917311"],"confidence":"Medium","gaps":["Whether these are primary or downstream effects unresolved","Mechanistic link to CLN8 molecular function not established"]},{"year":2012,"claim":"Defined a physical interactome (VAPA, GATE16, STX8, BNIP3/3L) and linked CLN8 to ceramide synthase activation, implicating it in lipid metabolism and trafficking.","evidence":"Split-ubiquitin membrane yeast two-hybrid with Co-IP/co-localization validation; ceramide synthase activity assays and MS in CLN8-/- cells with CLN5 complementation","pmids":["23142642","23160995"],"confidence":"Medium","gaps":["Direct enzymatic role versus indirect modulation of ceramide synthases unclear","Interactors validated only for a subset"]},{"year":2018,"claim":"Established CLN8's core molecular function as an ER cargo receptor for lysosomal enzymes and a regulator of PP2A activity, explaining lysosomal enzyme depletion in deficiency.","evidence":"Co-IP, luminal loop and COPII/COPI signal mutagenesis, lysosomal enzyme activity assays; Co-IP with PP2A/I2PP2A and cantharidin rescue in patient fibroblasts","pmids":["30397314","30453012"],"confidence":"High","gaps":["Identity of full cargo repertoire incomplete","How PP2A modulation integrates with cargo receptor role unresolved"]},{"year":2020,"claim":"Demonstrated that CLN8 acts within an obligate CLN6-CLN8 (EGRESS) complex functioning as a single unit for ER-to-Golgi enzyme relay.","evidence":"Reciprocal Co-IP, CLN6 luminal-loop mutagenesis, enzyme trafficking assays, and CLN6/CLN8 double-knockout epistasis in mice","pmids":["32597833"],"confidence":"High","gaps":["Stoichiometry and structure of the complex undetermined","Regulation of complex assembly unknown"]},{"year":2021,"claim":"Showed CLN8 loss disrupts endo-lysosomal dynamics, Golgi morphology, and lysosomal pH, and impairs dendritic development, connecting trafficking defects to neuronal phenotypes.","evidence":"shRNA knockdown with live pH imaging, vesicle tracking, Golgi morphometry, and dendritic morphology in primary neurons","pmids":["34021618"],"confidence":"Medium","gaps":["Causal chain from enzyme depletion to dendritic deficits not fully traced","Single lab"]},{"year":2024,"claim":"Identified impaired autophagy as a secondary pathological event amenable to pharmacological correction in CLN8 disease.","evidence":"cln8-deficient zebrafish model with trehalose and SG2 rescue","pmids":["38763444"],"confidence":"Medium","gaps":["Mechanistic link between cargo receptor loss and autophagy block not defined","Therapeutic relevance to mammals untested here"]},{"year":2025,"claim":"Resolved a direct catalytic activity for CLN8 as a lysophosphatidylglycerol acyltransferase in BMP biosynthesis, unifying its TLC-family identity with lysosomal phospholipid metabolism.","evidence":"In vitro acyltransferase reconstitution, lipidomics, and comparison with paralog TLCD1","pmids":["39970228"],"confidence":"High","gaps":["How acyltransferase activity is reconciled with the cargo receptor role unresolved","In vivo contribution of BMP synthesis to disease not quantified"]},{"year":null,"claim":"How CLN8's dual roles—enzyme cargo receptor in the EGRESS complex and LPG acyltransferase for BMP synthesis—are coordinated, and which is primary in driving neurodegeneration, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model integrating both functions","Relative disease contribution of each activity unmeasured","Substrate specificity in vivo undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[14]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[9,11]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,3]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[1,9,11]}],"pathway":[{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[9,11]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[14,8]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[9,11]}],"complexes":["EGRESS (CLN6-CLN8) complex"],"partners":["CLN6","VAPA","GATE16","STX8","BNIP3","BNIP3L","PP2A","I2PP2A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UBY8","full_name":"Protein CLN8","aliases":[],"length_aa":286,"mass_kda":32.8,"function":"Could play a role in cell proliferation during neuronal differentiation and in protection against cell death","subcellular_location":"Endoplasmic reticulum membrane; Endoplasmic reticulum-Golgi intermediate compartment membrane; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q9UBY8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLN8","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CLN8","total_profiled":1310},"omim":[{"mim_id":"620967","title":"TLC DOMAIN-CONTAINING PROTEIN 2; TLCD2","url":"https://www.omim.org/entry/620967"},{"mim_id":"620966","title":"TLC DOMAIN-CONTAINING PROTEIN 1; TLCD1","url":"https://www.omim.org/entry/620966"},{"mim_id":"615336","title":"CERAMIDE SYNTHASE 6; CERS6","url":"https://www.omim.org/entry/615336"},{"mim_id":"615335","title":"CERAMIDE SYNTHASE 5; CERS5","url":"https://www.omim.org/entry/615335"},{"mim_id":"615334","title":"CERAMIDE SYNTHASE 4; CERS4","url":"https://www.omim.org/entry/615334"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CLN8"},"hgnc":{"alias_symbol":["FLJ39417","TLCD6"],"prev_symbol":["EPMR","C8orf61"]},"alphafold":{"accession":"Q9UBY8","domains":[{"cath_id":"-","chopping":"20-257","consensus_level":"high","plddt":96.8556,"start":20,"end":257}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBY8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBY8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBY8-F1-predicted_aligned_error_v6.png","plddt_mean":90.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLN8","jax_strain_url":"https://www.jax.org/strain/search?query=CLN8"},"sequence":{"accession":"Q9UBY8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBY8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBY8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBY8"}},"corpus_meta":[{"pmid":"10508524","id":"PMC_10508524","title":"The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10508524","citation_count":235,"is_preprint":false},{"pmid":"12151215","id":"PMC_12151215","title":"TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?","date":"2002","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12151215","citation_count":137,"is_preprint":false},{"pmid":"15629147","id":"PMC_15629147","title":"A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15629147","citation_count":103,"is_preprint":false},{"pmid":"10861296","id":"PMC_10861296","title":"The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10861296","citation_count":92,"is_preprint":false},{"pmid":"30397314","id":"PMC_30397314","title":"CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis.","date":"2018","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30397314","citation_count":87,"is_preprint":false},{"pmid":"32597833","id":"PMC_32597833","title":"A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32597833","citation_count":70,"is_preprint":false},{"pmid":"22144673","id":"PMC_22144673","title":"Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the Tram-Lag-CLN8 (TLC) domain.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22144673","citation_count":57,"is_preprint":false},{"pmid":"16086686","id":"PMC_16086686","title":"Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16086686","citation_count":53,"is_preprint":false},{"pmid":"22388998","id":"PMC_22388998","title":"Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation.","date":"2012","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22388998","citation_count":48,"is_preprint":false},{"pmid":"23160995","id":"PMC_23160995","title":"CLN5 and CLN8 protein association with ceramide synthase: biochemical and proteomic approaches.","date":"2012","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/23160995","citation_count":46,"is_preprint":false},{"pmid":"19431184","id":"PMC_19431184","title":"A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19431184","citation_count":45,"is_preprint":false},{"pmid":"24953404","id":"PMC_24953404","title":"A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.","date":"2014","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24953404","citation_count":42,"is_preprint":false},{"pmid":"16570191","id":"PMC_16570191","title":"Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: Another genetic hit in the Mediterranean.","date":"2006","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/16570191","citation_count":38,"is_preprint":false},{"pmid":"33010819","id":"PMC_33010819","title":"AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease.","date":"2020","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33010819","citation_count":36,"is_preprint":false},{"pmid":"15160397","id":"PMC_15160397","title":"Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells.","date":"2004","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/15160397","citation_count":35,"is_preprint":false},{"pmid":"11589000","id":"PMC_11589000","title":"Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8.","date":"2001","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/11589000","citation_count":34,"is_preprint":false},{"pmid":"23142642","id":"PMC_23142642","title":"Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23142642","citation_count":30,"is_preprint":false},{"pmid":"21094208","id":"PMC_21094208","title":"Different early ER-stress responses in the CLN8(mnd) mouse model of neuronal ceroid lipofuscinosis.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/21094208","citation_count":27,"is_preprint":false},{"pmid":"19807737","id":"PMC_19807737","title":"Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis.","date":"2009","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19807737","citation_count":27,"is_preprint":false},{"pmid":"28024876","id":"PMC_28024876","title":"Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog.","date":"2016","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28024876","citation_count":26,"is_preprint":false},{"pmid":"17560505","id":"PMC_17560505","title":"A novel mutation of the CLN8 gene: is there a Mediterranean phenotype?","date":"2007","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17560505","citation_count":20,"is_preprint":false},{"pmid":"21917311","id":"PMC_21917311","title":"Deficient mitochondrial Ca(2+) buffering in the Cln8(mnd) mouse model of neuronal ceroid lipofuscinosis.","date":"2011","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/21917311","citation_count":20,"is_preprint":false},{"pmid":"29446145","id":"PMC_29446145","title":"Neuronal ceroid lipofuscinosis in Salukis is caused by a single base pair insertion in CLN8.","date":"2018","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29446145","citation_count":17,"is_preprint":false},{"pmid":"11332769","id":"PMC_11332769","title":"Studies of homogenous populations: CLN5 and CLN8.","date":"2001","source":"Advances in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11332769","citation_count":15,"is_preprint":false},{"pmid":"30453012","id":"PMC_30453012","title":"Neuronal ceroid lipofuscinosis related ER membrane protein CLN8 regulates PP2A activity and ceramide levels.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30453012","citation_count":14,"is_preprint":false},{"pmid":"31687336","id":"PMC_31687336","title":"Neuronal ceroid lipofuscinosis in a German Shorthaired Pointer associated with a previously reported CLN8 nonsense variant.","date":"2019","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/31687336","citation_count":14,"is_preprint":false},{"pmid":"34021618","id":"PMC_34021618","title":"The neuronal ceroid lipofuscinosis-related protein CLN8 regulates endo-lysosomal dynamics and dendritic morphology.","date":"2021","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/34021618","citation_count":13,"is_preprint":false},{"pmid":"8743986","id":"PMC_8743986","title":"Genetic and physical mapping of the progressive epilepsy with mental retardation (EPMR) locus on chromosome 8p.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8743986","citation_count":13,"is_preprint":false},{"pmid":"34044364","id":"PMC_34044364","title":"miR-3074-5p/CLN8 pathway regulates decidualization in recurrent miscarriage.","date":"2021","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34044364","citation_count":12,"is_preprint":false},{"pmid":"22964447","id":"PMC_22964447","title":"Phenotypic heterogeneity in consanguineous patients with a common CLN8 mutation.","date":"2012","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22964447","citation_count":11,"is_preprint":false},{"pmid":"28116333","id":"PMC_28116333","title":"CLN8 disease caused by large genomic deletions.","date":"2016","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28116333","citation_count":8,"is_preprint":false},{"pmid":"37121996","id":"PMC_37121996","title":"A novel candidate gene CLN8 regulates fat deposition in avian.","date":"2023","source":"Journal of animal science and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37121996","citation_count":7,"is_preprint":false},{"pmid":"38763444","id":"PMC_38763444","title":"Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model.","date":"2024","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/38763444","citation_count":7,"is_preprint":false},{"pmid":"26443629","id":"PMC_26443629","title":"Novel missense mutation in CLN8 in late infantile neuronal ceroid lipofuscinosis: The first report of a CLN8 mutation in Japan.","date":"2015","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/26443629","citation_count":7,"is_preprint":false},{"pmid":"30741402","id":"PMC_30741402","title":"Congenital CLN8 disease of neuronal ceroid lipofuscinosis: a novel phenotype.","date":"2019","source":"Revista de neurologia","url":"https://pubmed.ncbi.nlm.nih.gov/30741402","citation_count":7,"is_preprint":false},{"pmid":"34201538","id":"PMC_34201538","title":"CLN8 Mutations Presenting with a Phenotypic Continuum of Neuronal Ceroid Lipofuscinosis-Literature Review and Case Report.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34201538","citation_count":7,"is_preprint":false},{"pmid":"11588991","id":"PMC_11588991","title":"Northern epilepsy syndrome (NES, CLN8)--MRI and electrophysiological studies.","date":"2001","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/11588991","citation_count":7,"is_preprint":false},{"pmid":"30919163","id":"PMC_30919163","title":"The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.","date":"2019","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30919163","citation_count":6,"is_preprint":false},{"pmid":"27844444","id":"PMC_27844444","title":"Exome sequencing identifies a novel homozygous CLN8 mutation in a Turkish family with Northern epilepsy.","date":"2016","source":"Acta neurologica Belgica","url":"https://pubmed.ncbi.nlm.nih.gov/27844444","citation_count":6,"is_preprint":false},{"pmid":"33358637","id":"PMC_33358637","title":"Status dystonicus associated with CLN8 disease.","date":"2020","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/33358637","citation_count":5,"is_preprint":false},{"pmid":"39970228","id":"PMC_39970228","title":"TRAM-LAG1-CLN8 family proteins are acyltransferases regulating phospholipid composition.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/39970228","citation_count":4,"is_preprint":false},{"pmid":"36011304","id":"PMC_36011304","title":"CLN8 Gene Compound Heterozygous Variants: A New Case and Protein Bioinformatics Analyses.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36011304","citation_count":4,"is_preprint":false},{"pmid":"36369162","id":"PMC_36369162","title":"Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8mnd mice.","date":"2022","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36369162","citation_count":4,"is_preprint":false},{"pmid":"38751748","id":"PMC_38751748","title":"Two compound heterozygous variants in the CLN8 gene are responsible for neuronal cereidolipofuscinoses disorder in a child: a case report.","date":"2024","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/38751748","citation_count":1,"is_preprint":false},{"pmid":"42087192","id":"PMC_42087192","title":"TRAM-LAG1-CLN8 domain-containing protein TMEM56 regulates cell migration by changing intracellular ceramide levels.","date":"2026","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/42087192","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.10.25333392","title":"Identification and Validation of a Lipid Metabolism-associated Gene Signature for Predicting Survival in Sepsis Patients","date":"2025-08-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.10.25333392","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24521,"output_tokens":4033,"usd":0.067029,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11883,"output_tokens":3613,"usd":0.07487,"stage2_stop_reason":"end_turn"},"total_usd":0.141899,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"CLN8 encodes a novel putative transmembrane protein; a missense mutation (R24G) in EPMR patients and a frameshift insertion in mnd mice were identified as disease-causing, establishing CLN8 as the gene underlying these NCL phenotypes.\",\n      \"method\": \"Positional cloning, mutation analysis, sequence conservation analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — positional cloning with mutation identification replicated across human EPMR patients and mnd mouse model, independently confirming orthologous gene\",\n      \"pmids\": [\"10508524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CLN8 protein (~33 kDa) is an ER-resident protein that cycles between the ER and ERGIC; the C-terminal KKRP motif acts as an ER-retrieval signal, as mutation of KKRP redirects CLN8 to the Golgi; the mnd mutant protein is restricted to the ER, while the EPMR mutation (R24G) does not alter ER-ERGIC localization.\",\n      \"method\": \"Confocal immunofluorescence microscopy with organelle markers, western blotting, pulse-chase analysis, site-directed mutagenesis of KKRP retrieval signal, expression in BHK/HeLa/CHO cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct localization with functional mutagenesis of ER retrieval signal, multiple cell lines, replicated with pulse-chase\",\n      \"pmids\": [\"10861296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CLN8 was identified as a member of the TLC (TRAM-LAG1-CLN8) domain family, related to yeast Lag1p and mammalian TRAM, suggesting a conserved role in lipid sensing, ceramide synthesis, or lipid regulation in the ER.\",\n      \"method\": \"Bioinformatic sequence analysis and domain identification\",\n      \"journal\": \"Trends in biochemical sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational/bioinformatic prediction only, no direct experimental validation of CLN8 function in this paper\",\n      \"pmids\": [\"12151215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In mouse hippocampal neurons, CLN8 localizes to the ER (consistent with non-neuronal cells); in polarized epithelial CaCo-2 cells, CLN8 shows basolateral targeting; brain fractionation shows endogenous Cln8 in light membrane fractions distinct from ER in polarized cells. Disease-causing mutations do not alter intracellular localization in neuronal or non-neuronal cells.\",\n      \"method\": \"Semliki Forest virus-mediated expression, immunofluorescence microscopy with subcellular markers, subcellular fractionation of mouse brain tissue, polarized epithelial cell targeting assay\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct localization in primary neurons and polarized cells with fractionation, single lab, multiple complementary methods\",\n      \"pmids\": [\"15160397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CLN8 plays a role in cell proliferation during neuronal differentiation and in protection against cell death; expression of native CLN8 or mutant forms (including novel p.Lys61del and three previously described missense mutations) in neuronal cell models, validated by gene silencing, demonstrated these functions.\",\n      \"method\": \"Overexpression of wild-type and mutant CLN8 in neuronal cell models, gene silencing (siRNA knockdown), cell proliferation and apoptosis assays\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — loss-of-function (silencing) and gain-of-function with defined cellular phenotype, single lab, two orthogonal approaches\",\n      \"pmids\": [\"19431184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In CLN8(mnd) mice, ER stress markers are activated early and differentially across CNS regions: GRP78 upregulation and ATF6 activation occur presymptomatically in all regions; CHOP-dependent and caspase-12-dependent pathways are activated in a region-specific manner; NF-κB, TRAF2, TNF-α, and TNFR1 are also elevated, but ASK-1/JNK signaling is not activated. These ER stress responses contribute to CLN8(mnd) disease progression.\",\n      \"method\": \"Western blotting and immunohistochemistry for ER stress markers in Cln8mnd mouse CNS tissues at presymptomatic and symptomatic stages\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct measurement of ER stress pathway components in disease model, multiple regions and time points, single lab\",\n      \"pmids\": [\"21094208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In Cln8(mnd) hippocampal neurons, mitochondrial Ca2+ uptake is specifically impaired, reducing Ca2+ clearance efficiency; SERCA-mediated ER Ca2+ uptake and plasma membrane Ca2+ extrusion are unaffected. Cln8mnd neurons show increased vulnerability to excitotoxic glutamate-induced Ca2+ deregulation.\",\n      \"method\": \"Patch clamp, fluorescence Ca2+ imaging, caged Ca2+ photolysis in hippocampal slices and cultured neurons from Cln8mnd mice; pharmacological dissection of Ca2+ clearance pathways\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple electrophysiology and imaging methods in primary neurons, single lab, mechanistically specific (mitochondrial Ca2+ selective impairment)\",\n      \"pmids\": [\"21917311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CLN8 protein interacts with VAPA, c14orf1/hERG28, STX8, GATE16, BNIP3 and BNIP3L by split-ubiquitin membrane yeast two-hybrid screen; interactions with VAPA and GATE16 were validated by co-immunoprecipitation and co-localization in mammalian cells and CNS tissues, implicating CLN8 in lipid transport, vesicular trafficking, autophagy/mitophagy, and apoptosis.\",\n      \"method\": \"Split-ubiquitin membrane yeast two-hybrid (MYTH) screen, co-immunoprecipitation, co-localization immunofluorescence in mammalian cells and CNS tissue\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — yeast two-hybrid with reciprocal Co-IP and co-localization validation for two partners, single lab\",\n      \"pmids\": [\"23142642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CLN8-deficient cells show decreased ceramide synthase activity and reduced C16/C18:0/C24:0/C24:1 ceramide species (measured by MS), and CLN8 protein can complement defects in CLN5-deficient cells (growth, apoptosis), suggesting CLN8 and CLN5 are functionally related as activators of (dihydro)ceramide synthases.\",\n      \"method\": \"Ceramide synthase activity assay, mass spectrometry of ceramide species in CLN8-/- cells, complementation of CLN5-deficient cells by CLN8 overexpression\",\n      \"journal\": \"Electrophoresis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct enzymatic activity measurement and MS quantification in disease cells, complementation assay, single lab\",\n      \"pmids\": [\"23160995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CLN8 functions as an ER cargo receptor for lysosomal enzymes: it binds lysosomal enzymes via its second luminal loop (binding abolished by disease-causing mutations in this region), and traffics from ER to Golgi via COPII (export signal) and COPI (retrieval signal) interactions in its cytosolic C-terminus. CLN8 deficiency depletes soluble lysosomal enzymes and impairs lysosome biogenesis.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping and mutagenesis (luminal loop, COPII/COPI signals), lysosomal enzyme activity assays, CLN8 knockdown/knockout with lysosomal functional readouts\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (Co-IP, mutagenesis of functional domains, trafficking assays, enzyme activity), mechanistically rigorous, published in high-impact journal\",\n      \"pmids\": [\"30397314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CLN8 interacts with PP2A and its inhibitor I2PP2A; CLN8-deficient patient fibroblasts show decreased phosphorylation of PP2A substrates Akt, S6 kinase, and GSK3β (reversed by PP2A inhibitor cantharidin), indicating elevated PP2A activity. Ceramide levels are reduced by ~60% in CLN8-deficient cells, but ER-to-Golgi ceramide transport is not impaired.\",\n      \"method\": \"Co-immunoprecipitation of CLN8 with PP2A/I2PP2A, phosphorylation assays in patient fibroblasts, cantharidin rescue experiment, NBD-C6-ceramide transport assay, ceramide quantification\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP for protein interaction, pharmacological rescue, lipid transport assay, single lab\",\n      \"pmids\": [\"30453012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CLN6 forms an obligate complex with CLN8 (termed EGRESS: ER-to-Golgi relaying of enzymes of the lysosomal system) to recruit and transport lysosomal enzymes from the ER to the Golgi; the second luminal loop of CLN6 is required for enzyme binding but not for CLN6-CLN8 interaction. Mice lacking both CLN6 and CLN8 do not show aggravated pathology compared to single knockouts, confirming the complex acts as a functional unit.\",\n      \"method\": \"Co-immunoprecipitation, domain mutagenesis (CLN6 luminal loop), lysosomal enzyme trafficking assays in vitro and in vivo, double-knockout mouse epistasis analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reciprocal Co-IP, domain mutagenesis, in vivo double-knockout epistasis, multiple orthogonal methods confirming complex and functional unit\",\n      \"pmids\": [\"32597833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CLN8 knockdown in neuronal and non-neuronal cells increases Golgi apparatus size, increases the number and speed of mobile endo-lysosomes, and causes lysosomal alkalinization (detected with mApple-LAMP1-pHluorin). In primary rat hippocampal neurons, CLN8 knockdown reduces dendritic complexity and size, establishing a role for CLN8 in endo-lysosomal dynamics and somatodendritic development.\",\n      \"method\": \"shRNA knockdown, live fluorescence imaging (mApple-LAMP1-pHluorin pH reporter), vesicle tracking, Golgi morphometry, dendritic morphology analysis in primary neurons\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — loss-of-function with multiple functional readouts in neuronal and non-neuronal cells, single lab, direct functional imaging\",\n      \"pmids\": [\"34021618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CLN8 deficiency impairs autophagy in a zebrafish model; autophagy modulators trehalose and SG2 attenuate the pathological phenotype in cln8-deficient zebrafish larvae, establishing autophagy impairment as a secondary pathological event in CLN8 disease.\",\n      \"method\": \"Zebrafish cln8 knockout model, autophagy pathway analysis, pharmacological rescue with trehalose and SG2\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — in vivo loss-of-function model with pharmacological rescue establishing pathway involvement, single lab\",\n      \"pmids\": [\"38763444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CLN8 is a lysophosphatidylglycerol (LPG) acyltransferase that catalyzes an essential step in the biosynthesis of bis(monoacylglycero)phosphate (BMP), a phospholipid critical for lysosome function; this establishes CLN8 as a phospholipid remodeling enzyme within the TRAM-LAG1-CLN8 (TLC) domain protein family.\",\n      \"method\": \"In vitro acyltransferase activity assay, lipidomics, biochemical reconstitution of BMP biosynthesis, comparison with paralog TLCD1 (lysophosphatidylethanolamine acyltransferase)\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic reconstitution establishing acyltransferase activity, lipidomic validation, mechanistically definitive\",\n      \"pmids\": [\"39970228\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CLN8 is an ER-resident transmembrane protein that functions as both a lysophosphatidylglycerol acyltransferase (catalyzing a key step in bis(monoacylglycero)phosphate biosynthesis critical for lysosome function) and an ER cargo receptor: in complex with CLN6 (the EGRESS complex), CLN8 binds lysosomal enzymes via its second luminal loop and shuttles them from the ER to the Golgi via COPII export and COPI retrieval signals in its cytosolic C-terminus, with CLN8 deficiency depleting lysosomal enzymes, impairing lysosome biogenesis, dysregulating ceramide levels, elevating PP2A activity, and causing endo-lysosomal dysfunction and neurodegeneration.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CLN8 is an ER-resident transmembrane protein of the TRAM-LAG1-CLN8 (TLC) domain family that links lysosomal enzyme delivery and phospholipid metabolism, and whose loss causes neuronal ceroid lipofuscinosis: distinct mutations underlie human EPMR (R24G) and the murine mnd phenotype [#0]. The protein localizes to the ER and cycles to the ERGIC, with a C-terminal KKRP motif serving as an ER-retrieval signal whose mutation redirects CLN8 to the Golgi [#1]. Mechanistically, CLN8 acts as an ER cargo receptor for soluble lysosomal enzymes, binding them through its second luminal loop—an interaction abolished by disease mutations in this region—and shuttling them from the ER to the Golgi via COPII export and COPI retrieval signals in its cytosolic C-terminus, such that CLN8 deficiency depletes lysosomal enzymes and impairs lysosome biogenesis [#9]. This receptor function is executed within an obligate complex with CLN6 (the EGRESS complex), which operates as a single functional unit [#11]. Independently, CLN8 is a lysophosphatidylglycerol acyltransferase catalyzing an essential step in biosynthesis of the lysosomal phospholipid bis(monoacylglycero)phosphate (BMP) [#14]. CLN8 loss perturbs sphingolipid homeostasis, reducing ceramide synthase activity and ceramide species [#8], and elevates PP2A activity through interaction with PP2A and its inhibitor I2PP2A [#10]. Downstream consequences include endo-lysosomal dysfunction with Golgi enlargement and lysosomal alkalinization [#12], impaired autophagy [#13], and ER stress and calcium-handling defects in disease models [#5, #6].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the genetic identity of CLN8, answering which gene underlies EPMR and the mnd neurodegenerative phenotype.\",\n      \"evidence\": \"Positional cloning and mutation analysis in human EPMR patients and mnd mice\",\n      \"pmids\": [\"10508524\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protein function unknown at this stage\", \"No subcellular localization or biochemical activity defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined CLN8 as an ER-resident protein cycling to the ERGIC and identified the KKRP C-terminal ER-retrieval signal, framing it as a trafficking/secretory pathway component.\",\n      \"evidence\": \"Confocal immunofluorescence, pulse-chase, and site-directed mutagenesis of the KKRP motif in multiple cell lines\",\n      \"pmids\": [\"10861296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cargo or molecular activity not identified\", \"Mechanism of retrieval beyond signal mapping unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed CLN8 in the TLC domain family, raising the hypothesis of a lipid-related ER function.\",\n      \"evidence\": \"Bioinformatic sequence and domain analysis\",\n      \"pmids\": [\"12151215\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational prediction only, no experimental validation of lipid function in this work\", \"Specific enzymatic activity not demonstrated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked CLN8 to cellular phenotypes of neuronal proliferation and survival, moving beyond localization toward functional consequence.\",\n      \"evidence\": \"Overexpression of wild-type/mutant CLN8 and siRNA silencing in neuronal cell models with proliferation and apoptosis assays\",\n      \"pmids\": [\"19431184\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism behind proliferation/survival role not defined\", \"Single lab, cell-model based\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected CLN8 loss to ER stress and impaired mitochondrial calcium handling, identifying stress pathways contributing to disease progression.\",\n      \"evidence\": \"ER stress marker profiling in Cln8mnd CNS and electrophysiology/Ca2+ imaging in mutant hippocampal neurons\",\n      \"pmids\": [\"21094208\", \"21917311\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether these are primary or downstream effects unresolved\", \"Mechanistic link to CLN8 molecular function not established\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined a physical interactome (VAPA, GATE16, STX8, BNIP3/3L) and linked CLN8 to ceramide synthase activation, implicating it in lipid metabolism and trafficking.\",\n      \"evidence\": \"Split-ubiquitin membrane yeast two-hybrid with Co-IP/co-localization validation; ceramide synthase activity assays and MS in CLN8-/- cells with CLN5 complementation\",\n      \"pmids\": [\"23142642\", \"23160995\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct enzymatic role versus indirect modulation of ceramide synthases unclear\", \"Interactors validated only for a subset\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established CLN8's core molecular function as an ER cargo receptor for lysosomal enzymes and a regulator of PP2A activity, explaining lysosomal enzyme depletion in deficiency.\",\n      \"evidence\": \"Co-IP, luminal loop and COPII/COPI signal mutagenesis, lysosomal enzyme activity assays; Co-IP with PP2A/I2PP2A and cantharidin rescue in patient fibroblasts\",\n      \"pmids\": [\"30397314\", \"30453012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of full cargo repertoire incomplete\", \"How PP2A modulation integrates with cargo receptor role unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated that CLN8 acts within an obligate CLN6-CLN8 (EGRESS) complex functioning as a single unit for ER-to-Golgi enzyme relay.\",\n      \"evidence\": \"Reciprocal Co-IP, CLN6 luminal-loop mutagenesis, enzyme trafficking assays, and CLN6/CLN8 double-knockout epistasis in mice\",\n      \"pmids\": [\"32597833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structure of the complex undetermined\", \"Regulation of complex assembly unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed CLN8 loss disrupts endo-lysosomal dynamics, Golgi morphology, and lysosomal pH, and impairs dendritic development, connecting trafficking defects to neuronal phenotypes.\",\n      \"evidence\": \"shRNA knockdown with live pH imaging, vesicle tracking, Golgi morphometry, and dendritic morphology in primary neurons\",\n      \"pmids\": [\"34021618\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from enzyme depletion to dendritic deficits not fully traced\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified impaired autophagy as a secondary pathological event amenable to pharmacological correction in CLN8 disease.\",\n      \"evidence\": \"cln8-deficient zebrafish model with trehalose and SG2 rescue\",\n      \"pmids\": [\"38763444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between cargo receptor loss and autophagy block not defined\", \"Therapeutic relevance to mammals untested here\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved a direct catalytic activity for CLN8 as a lysophosphatidylglycerol acyltransferase in BMP biosynthesis, unifying its TLC-family identity with lysosomal phospholipid metabolism.\",\n      \"evidence\": \"In vitro acyltransferase reconstitution, lipidomics, and comparison with paralog TLCD1\",\n      \"pmids\": [\"39970228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How acyltransferase activity is reconciled with the cargo receptor role unresolved\", \"In vivo contribution of BMP synthesis to disease not quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CLN8's dual roles—enzyme cargo receptor in the EGRESS complex and LPG acyltransferase for BMP synthesis—are coordinated, and which is primary in driving neurodegeneration, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model integrating both functions\", \"Relative disease contribution of each activity unmeasured\", \"Substrate specificity in vivo undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [9, 11]},\n      {\"term_id\": \"GO:0016747\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1, 9, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [9, 11]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [14, 8]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [9, 11]}\n    ],\n    \"complexes\": [\"EGRESS (CLN6-CLN8) complex\"],\n    \"partners\": [\"CLN6\", \"VAPA\", \"GATE16\", \"STX8\", \"BNIP3\", \"BNIP3L\", \"PP2A\", \"I2PP2A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}